Global Biologics Market projected to reach USD 977.36 billion by 2032 with a CAGR of 9.46%.
From GlobeNewswire: 2025-03-18 10:00:00
The Global Biologics Market was valued at USD 433.77 billion in 2023, projected to reach USD 977.36 billion by 2032, with a CAGR of 9.46%. Biologics like monoclonal antibodies and gene therapies have transformed disease treatment. The market growth is driven by increased disease prevalence, research advancements, and regulatory support.
Key companies in the biologics market include Samsung Biologics, Amgen Inc., Novo Nordisk A/S, and more. The market scope includes a projected CAGR of 9.46% from 2024-2032 and regional coverage of North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Segment analysis covers sources like mammalian cells and products such as monoclonal antibodies.
Mammalian cells held a 65% market share in biologics manufacturing in 2023, known for generating complex proteins. Microbial systems are gaining popularity due to cost-effectiveness and fast production. Monoclonal antibodies dominated the market in 2023, with RNA interference medicines showing rapid growth potential. Regional analysis highlights North America as a leader, with Asia-Pacific showing rapid market growth.
Recent developments in the biologics market include FDA accepting the BLA for LEQEMBI for Alzheimer’s, partnerships for peptide-based drugs, and major manufacturing agreements. Samsung Biologics signed a large CMO deal, and Roche announced an expansion of biologics manufacturing facilities to meet global demand. RNA-based therapies are rapidly growing, with over 500 biologics candidates in clinical trials. Governments invested USD 50 billion in biologics research in 2023, while private sector funding rises. Biopharma companies are expanding manufacturing facilities, expecting a 20% increase in global production capacity by 2032. Advancements in bioreactor technology improve production efficiency.
For more details, access the Biologics Market Analysis & Outlook Report 2024-2032 at https://www.snsinsider.com/checkout/5539. The report covers key points like market dynamics, incidence of chronic diseases, prescription trends, healthcare spending, competitive landscape, regional analysis, and company profiles. Customize research or inquire at [email protected].
SNS Insider is a leading global market research and consulting agency, providing clients with current and accurate market data, consumer insights, and opinions. Using various techniques like surveys, video talks, and focus groups, we aim to empower clients to make informed decisions in a rapidly changing market landscape. Visit https://www.snsinsider.com/reports/biologics-market-5539 for more information.
Read more at GlobeNewswire: Global Biologics Market Size Projected to Reach USD 977.36